Market Tracker

08/26 5:16pm ET

Puma Biotechnology Inc (NYSE:PBYI)

57.63
Delayed Data
As of Aug 26
 +0.68 / +1.19%
Today’s Change
19.74
Today|||52-Week Range
107.49
-26.49%
Year-to-Date
4 Biotech Stock Charts You Must See
Aug 23 / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Apple, Exact Sciences, Amkor Technology, Puma Biot...
Aug 19 / Zacks.com - Paid Partner Content
Puma (PBYI) Neratinib's Application Validated in EU, Stock Up
Aug 23 / Zacks.com - Paid Partner Content
4 Biggest Winners from This Earnings Season
Aug 18 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close56.95
Today’s open57.00
Day’s range56.06 - 59.32
Volume749,443
Average volume (3 months)737,897
Market cap$1.9B
Dividend yield--
Data as of 4:01pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-57.51%
Earnings growth (this year)-4.56%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book9.08

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...+0.11+0.46%
IRWDIronwood Pharmaceuti...+0.13+0.96%
ITCIIntra-Cellular Thera...+0.70+1.76%
PRTAProthena Corporation...+0.65+1.32%
Data as of 3:59pm ET, 08/26/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$1.96
Annual revenue (last year)$0.00
Annual profit (last year)-$239.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
Secretary
Alan H. Auerbach
Treasurer &
Senior VP-Finance & Administration
Charles R. Eyler
Corporate headquarters
Los Angeles, California

Forecasts